Tanabe Koji K - OmicsDI

Show results for

Transcriptomics (1)
Unknown (1)
Metabolomics (1)

Organisms

Homo sapiens (1)

Repository

biostudies-arrayexpress (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Flow Injection Analysis MS - Positive (FIA-MS (Positive)) (1)

Publication Date

2013 (1)
2019 (1)

CHEBI ID

CHEBI:67075 (1)
CHEBI:137629 (1)
CHEBI:66976 (1)
CHEBI:137605 (1)
CHEBI:66844 (1)
CHEBI:137557 (1)
CHEBI:137555 (1)
CHEBI:132059 (1)
CHEBI:137573 (1)
CHEBI:137649 (1)
CHEBI:137642 (1)
CHEBI:137589 (1)
CHEBI:137588 (1)
CHEBI:137587 (1)
CHEBI:72538 (1)
CHEBI:66974 (1)
CHEBI:137615 (1)
CHEBI:85760 (1)
CHEBI:133629 (1)
CHEBI:72505 (1)
CHEBI:85704 (1)
CHEBI:72539 (1)
CHEBI:72524 (1)
CHEBI:91322 (1)
CHEBI:137551 (1)
CHEBI:91052 (1)
CHEBI:85769 (1)
CHEBI:85767 (1)
CHEBI:137603 (1)
CHEBI:66846 (1)

Metabolite Name

PC-O(40:7) (1)
PC-O(40:6) (1)
PC-O(40:5) (1)
PC-O(40:4) (1)
PC-O(38:6) (1)
PC-O(38:5) (1)
PC-O(38:4) (1)
PC-O(38:3) (1)
PC-O(36:6) (1)
PC-O(36:5) (1)
PC-O(36:4) (1)
PC-O(36:3) (1)
PC-O(36:2) (1)
PC-O(34:4) (1)
PC-O(34:2) (1)
PC-O(34:1) (1)
PC-O(34:0) (1)
PC-O(33:3) (1)
PC-O(32:1) (1)
PC-O(32:0) (1)
PC-O(30:0) (1)
PC(46:2) (1)
PC(44:5) (1)
PC(44:3) (1)
PC(44:1) (1)
PC(43:6) (1)
PC(41:5) (1)
PC(37:7) (1)
PC(33:5) (1)
PC(33:4) (1)

Study type

Transcription profiling by array (1)

Release Date

2013 (1)
2022 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Maturation,not initiation, is major roadblock during reprogramming toward pluripotency from human fibrobalsts

Reprogrammed cells are reverted to non reprogrammed cell fate in a maturation step of reprogramming. Cell fate changes during reprogramming from fibroblasts to iPSC , N=60 fibrobalst lines, N=13 Undifferentiated pluripotent stem cells, N=16 Nascent reprogrammed cells, N=31

ORGANISM(S): Homo sapiens

2013-07-01 | E-GEOD-47489 | biostudies-arrayexpress

Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler

Inducing mitochondrial uncoupling (mUncoupling) is an attractive therapeutic strategy for treating metabolic diseases because it leads to calorie-wasting by reducing the efficiency of oxidative phosphorylation (OXPHOS) in mitochondria. Here we report a safe mUncoupler, OPC-163493, which has unique p...

2019-05-24 | MTBLS836 | MetaboLights

Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.

Not available

S-EPMC9128191 | biostudies-literature

Previous page
1 / 1
You're on page 1
Next page